A new study published in npj Aging provides compelling evidence that untreated obstructive sleep apnea (OSA) accelerates cardiovascular aging and significantly increases the risk of premature death.
Table of Contents
While most Americans know that smoking damages the heart, few realize that the nightly breathing interruptions of sleep apnea may impose an even more profound burden on the cardiovascular system. The condition affects an estimated 83 million American adults, yet the majority remain undiagnosed and untreated.
The implications extend far beyond feeling tired.
Prolonged intermittent hypoxia creates a cumulative burden on the cardiovascular system that accelerates biological aging and elevates mortality risk.
This silent epidemic deserves the same urgency we reserve for established cardiovascular threats.
The Hidden Mechanism Behind Accelerated Heart Aging
When breathing stops repeatedly during sleep, the body experiences dangerous drops in oxygen levels. These events trigger a cascade of physiological responses that stress the cardiovascular system night after night.
Frequent changes in oxygen levels can cause significant stress on the body, called oxidative stress, which can promote systemic inflammation, as well as neurochemical and physiological reactions that increase the risk of heart disease.
The damage compounds over time. Modern sleep therapy devices like CPAP NZ help maintain continuous airway pressure during sleep, preventing these oxygen drops before cardiovascular harm accumulates.
A high risk of OSA was associated with greater carotid intima-media thickness, Young’s elastic modulus, carotid-femoral pulse wave velocity, carotid pulse wave velocity, and carotid diameter.
These markers reveal arteries aging faster than chronological years would predict.
Six Years of Biological Aging in Your Blood Vessels
Recent genetic research has quantified the aging impact of untreated sleep apnea with striking precision.
A 2025 bidirectional Mendelian randomization analysis involving more than 820,000 genome-wide variants concluded that genetically predicted OSA shortens leukocyte telomeres by about 120 base pairs, which equates to roughly six years of additional biological aging.
Telomeres serve as protective caps on chromosomes, shortening with each cell division. When telomeres become critically short, cells age prematurely and die. This molecular clock reveals that severe untreated sleep apnea forces your cardiovascular cells to age biologically as if six additional years have passed.
The study found in the research on cardiovascular health literature confirms that cardiovascular disease remains a leading global health concern.
Severe obstructive sleep apnea was related to shorter leukocyte telomere length, and when compared with individuals without severe OSA, average length in those with OSA was comparable to telomere length differences of 10 years of immune cell aging.
Cardiovascular Consequences Beyond Traditional Risk Factors
The American Heart Association recognizes obstructive sleep apnea as an independent cardiovascular risk factor.
Between 40% and 80% of people in the U.S. with cardiovascular disease also have obstructive sleep apnea, yet it is underrecognized and undertreated in cardiovascular practice.
OSA affects 30% to 50% of people with high blood pressure and is a risk factor for atrial fibrillation, and is also associated with Type 2 diabetes, worse outcomes from heart failure and even sudden cardiac death.
The overlapping pathways between sleep apnea and cardiovascular disease create a dangerous feedback loop where each condition worsens the other.
Unlike smoking, which primarily damages through toxic chemical exposure, sleep apnea harms through repeated stress responses. Research from the NIH has helped clarify these mechanisms.
For every measure of observed reduction in blood oxygen levels, or hypoxic burden, a person had a 45% increased associated risk for having a primary cardiovascular event.
Mortality Risk That Rivals Major Health Threats
The long-term survival data paints a sobering picture for those with untreated severe sleep apnea.
One well-known study found that people with untreated severe obstructive sleep apnea were nearly four times more likely to die over the 20 years of the study than were those without the condition.
The research team examined how prolonged exposure to intermittent hypoxia during the time corresponding to usual sleep behaviors influences cardiovascular health across the lifespan, and in this model, prolonged intermittent hypoxia was associated with significantly higher mortality compared to normal oxygen conditions.
These statistics place untreated severe sleep apnea in the same mortality risk category as smoking and other established cardiovascular threats. The difference lies in awareness. Most people understand that smoking kills, yet millions sleep through nightly suffocation episodes without recognizing the equivalent danger.
Treatment Can Slow or Reverse the Damage
The encouraging news is that appropriate treatment appears to halt and potentially reverse cardiovascular aging from sleep apnea.
OSA-induced sleep disruptions and lower oxygen levels during sleep promoted faster biological age acceleration compared to the control group, however, the OSA patients who adhered to treatment showed a deceleration of the epigenetic age.
Studies published in PubMed demonstrate that continuous positive airway pressure remains the gold standard treatment.
A Brazilian trial found that six months of nightly treatment use of at least four hours stabilized telomere length, while in contrast, the control group lost an additional 65 base pairs, equivalent to approximately three biological years.
Early diagnosis and consistent treatment adherence prove critical.
Early screening and intervention, including the use of continuous positive airway pressure therapy and other treatment options, may play a key role in improving long-term cardiovascular outcomes, particularly in rural and underserved communities.
Recognition and Action Save Hearts
The cardiovascular consequences of untreated sleep apnea demand greater clinical and public awareness. This condition accelerates biological aging through mechanisms that stress the heart and blood vessels every single night. The cellular damage accumulates silently, aging cardiovascular tissue years beyond chronological age.
Medical evaluation should follow for anyone experiencing loud snoring, witnessed breathing pauses during sleep, or excessive daytime sleepiness. These symptoms signal that the cardiovascular system endures repeated oxygen deprivation. With proper diagnosis and treatment, the aging acceleration can stop, potentially adding years of healthy cardiovascular function.
The evidence is clear: untreated sleep apnea rivals smoking as a cardiovascular threat. The difference is that we have effective treatments available right now. Recognition and action remain the only barriers between preventable cardiovascular aging and healthier, longer lives.
As with anything you read on the internet, this article should not be construed as medical advice; please talk to your doctor or primary care provider before changing your wellness routine. WHN neither agrees nor disagrees with any of the materials posted. This article is not intended to provide a medical diagnosis, recommendation, treatment, or endorsement.
Opinion Disclaimer: The views and opinions expressed in this article are those of the author and do not necessarily reflect the official policy of WHN. Any content provided by guest authors is of their own opinion and is not intended to malign any religion, ethnic group, club, organization, company, individual, or anyone or anything else. The Food and Drug Administration has not evaluated these statements.
